Q/C Technologies, Inc. Shareholders' Equity
Q/C Technologies, Inc. (QCLS) had Shareholders' Equity of $16.09 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-12
- 2026-06-30: Stockholders' Equity Attributable to Parent $16.09M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $20.72M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $21.75M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $14.32M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $16.09M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $20.72M 10-Q · filed 2026-08-12 | |
| 2025-12-31 | $21.75M 10-Q · filed 2026-08-12 | |
| 2025-09-30 | $14.32M 10-Q · filed 2025-11-19 | |
| 2025-06-30 | $5.28M 10-Q · filed 2026-08-12 | |
| 2025-03-31 | $8.69M 10-Q · filed 2026-08-12 | |
| 2024-12-31 | $9.79M 10-Q · filed 2026-08-12 | |
| 2024-09-30 | $16.78M 10-Q · filed 2025-11-19 | |
| 2024-06-30 | $97.81K 10-Q · filed 2025-11-19 | |
| 2024-06-29 | $97.81K 10-Q · filed 2024-08-19 | |
| 2024-03-31 | $9.94M 10-Q · filed 2025-11-19 | |
| 2023-12-31 | $12.37M 10-K · filed 2026-04-15 | |
| 2023-09-30 | $15.50M 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $10.74M 10-Q · filed 2024-11-14 | |
| 2023-03-31 | $13.09M 10-Q · filed 2024-11-14 | |
| 2022-12-31 | $14.70M 10-K · filed 2025-04-11 | |
| 2022-09-30 | $18.33M 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $16.12M 10-Q · filed 2023-11-14 | |
| 2022-03-31 | $19.62M 10-Q · filed 2023-11-14 | $19.62M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $23.65M 10-K · filed 2024-04-01 | |
| 2021-09-30 | $25.89M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $31.07M 10-Q · filed 2022-11-10 | |
| 2021-03-31 | -$8.35M 10-Q · filed 2022-11-10 | $33.42M 10-Q · filed 2021-05-18 |
| 2020-12-31 | -$5.26M 10-K · filed 2023-03-31 | $34.58M 10-K · filed 2021-03-01 |
| 2020-09-30 | -$4.23M 10-Q/A · filed 2021-11-15 | $21.17M 10-Q · filed 2020-11-16 |
| 2020-06-30 | -$3.05M 10-Q/A · filed 2021-11-15 | $15.97M 10-Q · filed 2020-08-14 |
| 2020-03-31 | -$2.66M 10-Q/A · filed 2021-11-15 | $6.82M 10-Q · filed 2020-05-15 |
| 2019-12-31 | -$2.33M 10-K · filed 2022-03-31 | $9.36M 10-K · filed 2020-03-25 |
| 2019-12-29 | -$1.73M 10-Q · filed 2021-08-16 | |
| 2019-11-30 | -$1.73M 10-Q/A · filed 2021-11-15 | |
| 2019-09-30 | $3.60M 10-Q · filed 2020-11-16 | |
| 2019-06-30 | $4.31M 10-Q · filed 2020-11-16 | |
| 2019-03-31 | $4.97M 10-Q · filed 2020-11-16 | |
| 2018-12-31 | $5.83M 10-K · filed 2021-03-01 | |
| 2018-09-30 | $7.72M 10-Q · filed 2019-11-14 | |
| 2018-06-30 | $10.79M 10-Q · filed 2019-11-14 | |
| 2018-03-31 | $11.42M 10-Q · filed 2019-11-14 | |
| 2017-12-31 | $7.55M 10-K · filed 2020-03-25 | $9.11M 10-K · filed 2018-04-03 |
| 2017-09-30 | $3.80M 10-Q/A · filed 2018-07-13 | $3.95M 10-Q · filed 2017-11-14 |
| 2017-06-30 | $4.96M 10-Q/A · filed 2018-07-13 | $5.12M 10-Q · filed 2017-08-14 |
| 2017-03-31 | $5.75M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $3.39M 10-K · filed 2019-04-01 | |
| 2016-09-30 | $4.47M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $4.12M 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $5.11M 10-Q · filed 2016-05-12 | |
| 2015-12-31 | $6.60M 10-K/A · filed 2018-07-13 | |
| 2015-09-30 | $9.80M 10-Q · filed 2015-11-13 | |
| 2015-06-30 | $12.12M 10-Q · filed 2015-08-18 | |
| 2015-03-31 | $14.21M 10-Q · filed 2015-05-14 | |
| 2014-12-31 | $14.81M 10-K · filed 2017-04-11 | |
| 2014-09-30 | $15.73M 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $16.66M 10-Q · filed 2014-08-12 | |
| 2014-03-31 | $16.62M 10-Q · filed 2014-05-14 | |
| 2013-12-31 | $4.12M 10-K · filed 2016-03-30 | |
| 2012-12-31 | $3.30M 10-K · filed 2015-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |